Cargando…

Recurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): study protocol of a multicenter observational cohort study

BACKGROUND: After initial treatment of differentiated thyroid carcinoma (DTC) patients are followed with thyroglobulin (Tg) measurements to detect recurrences. In case of elevated levels of Tg and negative neck ultrasonography, patients are treated 'blindly' with Iodine-131 ((131)I). Howev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kist, Jakob W, de Keizer, Bart, Stokkel, Marcel PM, Hoekstra, Otto S, Vogel, Wouter V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058699/ https://www.ncbi.nlm.nih.gov/pubmed/24906384 http://dx.doi.org/10.1186/1471-2407-14-405

Ejemplares similares

Calibration of PET/CT scanners for multicenter studies on differentiated thyroid cancer with (124)I
por: Kist, Jakob W., et al.
Publicado: (2016)

Guidelines for quality control of PET/CT scans in a multicenter clinical study
por: Hristova, Ivalina, et al.
Publicado: (2017)

Effects of furosemide and tracer selection on urinary activity and peri-bladder artefacts in PSMA PET/CT: a single-centre retrospective study
por: Donswijk, Maarten L., et al.
Publicado: (2022)

Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology
por: Cheebsumon, Patsuree, et al.
Publicado: (2012)

Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter study
por: van der Hiel, Bernies, et al.
Publicado: (2017)

PET Imaging in Recurrent Medullary Thyroid Carcinoma
por: Treglia, Giorgio, et al.
Publicado: (2012)

PSMA PET/CT Identifies Intrapatient Variation in Salivary Gland Toxicity From Iodine-131 Therapy
por: Mohan, Vineet, et al.
Publicado: (2020)

Usefulness of PET-CT scan in recurrent thyroid cancer
por: Dionigi, Gianlorenzo, et al.
Publicado: (2020)

Clinical verification of (18)F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer
por: Meijer, Dennie, et al.
Publicado: (2020)

Is C‐11 Methionine PET an alternative to 18‐F FDG‐PET for identifying recurrent laryngeal cancer after radiotherapy?
por: Wedman, Jan, et al.
Publicado: (2018)

Diagnostic significance of MRI versus CT using identical PET data in patients with recurrent differentiated thyroid cancer: A PET/MRI study
por: Westphal, Korbinian, et al.
Publicado: (2023)

Usefulness of PET/CT with (18)F-FDG in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy: An Italian Multicenter Study
por: Filippi, Luca, et al.
Publicado: (2021)

Usefulness of PET/CT in the diagnosis of recurrent or metastasized differentiated thyroid carcinoma
por: LU, CUN-ZHI, et al.
Publicado: (2016)

Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis
por: Cysouw, Matthijs C. F., et al.
Publicado: (2017)

Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study
por: Donswijk, Maarten L., et al.
Publicado: (2020)

The cost-effectiveness of (18)FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy
por: van Hooren, Addy C. G., et al.
Publicado: (2008)

Preoperative Lymph Node Staging by FDG PET/CT With Contrast Enhancement for Thyroid Cancer: A Multicenter Study and Comparison With Neck CT
por: Chong, Ari, et al.
Publicado: (2017)

Clinical evaluation of respiration-induced attenuation uncertainties in pulmonary 3D PET/CT
por: Kruis, Matthijs F, et al.
Publicado: (2015)

Zirconium-89 labelled rituximab PET-CT imaging of Graves’ orbitopathy
por: de Keizer, Bart, et al.
Publicado: (2019)

Intra-arterial versus standard intravenous administration of lutetium-177-DOTA-octreotate in patients with NET liver metastases: study protocol for a multicenter, randomized controlled trial (LUTIA trial)
por: Ebbers, Sander C., et al.
Publicado: (2020)

Updating PET/CT performance standards and PET/CT interpretation criteria should go hand in hand
por: Boellaard, Ronald, et al.
Publicado: (2019)

Quantitative classification and radiomics of [(18)F]FDG-PET/CT in indeterminate thyroid nodules
por: de Koster, Elizabeth J., et al.
Publicado: (2022)

Impact of (68)GA-PSMA PET / CT on treatment of patients with recurrent / metastatic high risk prostate cancer - a multicenter study
por: Mattiolli, Aline B., et al.
Publicado: (2018)

PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups: An International Multicenter Study
por: Ferdinandus, Justin, et al.
Publicado: (2022)

Metabolically active tumour volume segmentation from dynamic [(18)F]FLT PET studies in non-small cell lung cancer
por: Hoyng, Lieke L, et al.
Publicado: (2015)

An integrated personalized assistive devices approach to reduce the risk of foot ulcer recurrence in diabetes (DIASSIST): study protocol for a multicenter randomized controlled trial
por: Vossen, Lisa E., et al.
Publicado: (2023)

Analysis of predictability of F‐18 fluorodeoxyglucose‐PET/CT in the recurrence of papillary thyroid carcinoma
por: Kim, Suk Kyeong, et al.
Publicado: (2016)

The Use of (18)F-FDG PET/CT in Patients with Recurrent Differentiated Thyroid Cancer
por: Ekmekçioğlu, Özgül
Publicado: (2021)

Colorectal cancer: the role of PET/CT in recurrence: Wednesday 5 October 2005, 14:00–16:00
por: Vogel, Wouter V, et al.
Publicado: (2005)

TSH suppression aggravates arterial inflammation — an (18)F-FDG PET study in thyroid carcinoma patients
por: Boswijk, Ellen, et al.
Publicado: (2019)

Partial volume correction strategies for quantitative FDG PET in oncology
por: Hoetjes, Nikie J., et al.
Publicado: (2010)

Interobserver reproducibility of tumor uptake quantification with (89)Zr-immuno-PET: a multicenter analysis
por: Jauw, Yvonne W. S., et al.
Publicado: (2019)

Risk factors for recurrent disease in small papillary thyroid cancers – a Swedish register-based study
por: Bayadsi, Haytham, et al.
Publicado: (2023)

Effectiveness of [(124)I]-PET/CT and [(18)F]-FDG-PET/CT for Localizing Recurrence in Patients with Differentiated Thyroid Carcinoma
por: Lee, Jandee, et al.
Publicado: (2012)

Post-PET ultrasound improves specificity of 18F-FDG-PET for recurrent differentiated thyroid cancer while maintaining sensitivity
por: Biermann, Martin, et al.
Publicado: (2015)

Zirconium-89-labelled rituximab PET-CT in orbital inflammatory disease
por: Laban, Kamil G., et al.
Publicado: (2019)

Association of Hyperparathyroidism and Papillary Thyroid Cancer: A Multicenter Retrospective Study
por: Jeong, Chaiho, et al.
Publicado: (2020)

Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study
por: Ríos, A., et al.
Publicado: (2022)

Detection of Synchronous Parathyroid Adenoma and Breast Cancer with (18)F-Fluorocholine PET-CT
por: Vorselaars, Wessel MCM, et al.
Publicado: (2015)

Buddhist-like opposite diminishing and non-judging during ketamine infusion are associated with antidepressant response: an open-label personalized-dosing study
por: Stocker, Kurt, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ckndlqupdecvt5ec9hlij4f75c